Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage).

PubWeight™: 3.26‹?› | Rank: Top 1%

🔗 View Article (PMID 1111935)

Published in Cancer on March 01, 1975

Authors

H J Wanebo, J Woodruff, J G Fortner

Articles citing this

Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma. Ann Surg (1975) 4.24

Results of treatment of 269 patients with primary cutaneous melanoma: a five-year prospective study. Ann Surg (1977) 1.58

Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg (1977) 1.55

Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow). Ann Surg (1975) 1.52

The extent of primary melanoma excision. A re-evaluation--how wide is wide? Ann Surg (1983) 1.45

Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. Ann Surg (1982) 1.38

Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg (2001) 1.36

The incidental malignant melanoma. Br Med J (Clin Res Ed) (1983) 1.35

Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat. Ann Surg (1981) 1.34

Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg (1991) 1.27

A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models. Ann Surg (1982) 1.24

Current management of melanoma. Ann Surg (1977) 0.97

Missed malignant melanomas. Br Med J (Clin Res Ed) (1986) 0.94

The accuracy of predicting lymph nodes metastases in malignant melanoma by clinical examination and microstaging. Ann Surg (1976) 0.92

Sentinel lymph node biopsy progress in surgical treatment of cancer. Langenbecks Arch Surg (2004) 0.87

The treatment of state I melanoma of the extremities with regional hyperthermic isolation perfusion. Ann Surg (1982) 0.86

Pagetoid malignant melanoma and lentigo maligna melanoma of toe. A study with the fluorescence method (Falck and Hillarp). Arch Dermatol Res (1978) 0.84

Judging prognosis in malignant melanoma of the skin. A problem of inference over small data sets. Ann Surg (1983) 0.83

Early metastases in regional lymph nodes and prognosis of malignant melanoma. Histological and clinical examinations in 104 lymphadenectomized patients. Arch Dermatol Res (1976) 0.81

Frequency of occult residual melanoma after excision of a clinically positive regional lymph node. Ann Surg (1987) 0.77

Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression. Ann Surg (1985) 0.77

Diagnosis, treatment and prognosis of early melanoma. The importance of depth of microinvasion. Ann Surg (1980) 0.75

The Queensland Melanoma Project. Br Med J (1979) 0.75

Articles by these authors

Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol (1996) 5.40

Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88

SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med (1998) 4.18

Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg (1984) 3.96

Younger women with breast carcinoma have a poorer prognosis than older women. Cancer (1996) 3.54

Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42

Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery (1986) 3.22

Lymphocytes: circulation altered by trypsin. Science (1968) 2.99

Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer (1993) 2.89

Major hepatic resection for neoplasia: personal experience in 108 patients. Ann Surg (1978) 2.80

Giant hemangiomas of the liver. Ann Surg (1970) 2.70

Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med (1978) 2.69

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68

Orthotopic and heterotopic liver homografts in man. Ann Surg (1970) 2.63

Regional resection of cancer of the pancreas: a new surgical approach. Surgery (1973) 2.43

Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg (1996) 2.39

Epidemiology of cancer of the pancreas. J Natl Cancer Inst (1973) 2.37

Surgical treatment of 297 soft tissue sarcomas of the lower extremity. Ann Surg (1975) 2.31

Major hepatic resection using vascular isolation and hypothermic perfusion. Ann Surg (1974) 2.30

Malignant schwannoma. A clinicopathologic study. Cancer (1973) 2.26

Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum (1988) 2.20

Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06

Giant condyloma acuminatum (Buschke-Lowenstein tumor) of the anorectal and perianal regions. Analysis of 42 cases. Dis Colon Rectum (1994) 2.04

Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Tumor staging and results. Ann Surg (1984) 2.03

Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Ann Surg (1977) 1.96

The continuing challenge of retroperitoneal sarcomas. Cancer (1981) 1.95

Management of small soft-tissue sarcoma of the extremity in adults. Arch Surg (1992) 1.92

Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg (1995) 1.91

The effect of surgical wounding on tumour development. Eur J Surg Oncol (1999) 1.88

The case for and technique of heterotopic liver grafting. Transplant Proc (1979) 1.87

Proceedings: Treatment of minimal breast cancer. Cancer (1974) 1.78

Anorectal melanoma. Cancer (1981) 1.77

Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg (1996) 1.77

Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery (1997) 1.68

The seventies evolution in liver surgery for cancer. Cancer (1981) 1.68

Paraproteinemia and reticulum cell sarcoma in an inbred mouse strain. Science (1966) 1.65

Multifactorial analysis of long-term follow-up (more than 5 years) of primary extremity sarcoma. Arch Surg (1999) 1.54

Treatment of primary and secondary liver cancer by hepatic artery ligation and infusion chemotherapy. Ann Surg (1973) 1.53

Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow). Ann Surg (1975) 1.52

Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg (1978) 1.49

Hepatic resection for metastasis from colorectal cancer. Dis Colon Rectum (1978) 1.44

Clinical manifestations of hepatoma. A review of 6 years' experience at a cancer hospital. Am J Med (1974) 1.42

Endoscopic diagnosis of advanced gastric cancer. Factors influencing yield. Gastroenterology (1975) 1.40

T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg (1975) 1.40

Phytohemagglutinin: inhibition of the agglutinating activity by N-acetyl-D-galactosamine. Science (1966) 1.34

The role of radiotherapy in the management of malignant hemangiopericytoma: report of eleven new cases and review of the literature. Cancer (1977) 1.33

Local recurrence of gastric adenocarcinomas after gastrectomy. J Surg Oncol (1981) 1.32

Adverse effect of pregnancy on melanoma: a reappraisal. Cancer (1976) 1.31

Immunogenic properties of reticulum cell sarcomas of SJL/J mice. J Natl Cancer Inst (1970) 1.30

Tendosynovial sarcoma: a clinicopathological study of 136 cases. Cancer (1977) 1.30

Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoids. Cancer Res (1981) 1.29

Diagnosis and management of giant intrasacral schwannoma. Cancer (1992) 1.28

A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma. Cancer (1996) 1.27

Experimental use of a gastric flap on an omental pedicle to close defects in the trachea, pharynx, or cervical esophagus. Plast Reconstr Surg (1977) 1.27

Biostatistical basis of elective node dissection for malignant melanoma. Ann Surg (1977) 1.27

Tumor vascularity as a prognostic factor for hepatic tumors. Ann Surg (1977) 1.26

Adenocarcinoma of the gastric cardia. The choice of gastrectomy. Ann Surg (1980) 1.26

Surgical management of carcinoma of the junction of the main hepatic ducts. Ann Surg (1976) 1.25

Outcome of treatment for distal bile duct cancer. Br J Surg (1996) 1.25

Primary lymphoma of the liver. Cancer (1988) 1.24

Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg (1995) 1.24

A case control study of cancer of the pancreas. Cancer (1973) 1.23

Morphological studies of rejection in canine jejunal allographs. Gastroenterology (1971) 1.23

Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer. II. Treatment by intrahepatic chemotherapy. Ann Surg (1984) 1.23

Bilateral breast cancer. Risk reduction by contralateral biopsy. Ann Surg (1985) 1.22

Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg (1998) 1.22

Metabolic consequences of (regional) total pancreatectomy. Ann Surg (1991) 1.22

Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131) Ann Surg (1994) 1.21

Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer (1993) 1.20

Decreased complement mediated binding of antibody/3H-dsDNA immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies. Arthritis Rheum (1983) 1.19

Treatment of primary and recurrent retroperitoneal liposarcoma. Twenty-five-year experience at Memorial Hospital. Cancer (1973) 1.19

A simple method of orthotopic liver transplantation in dogs. Ann Surg (1982) 1.18

Occlusion of the hepatic artery in man. Surg Gynecol Obstet (1973) 1.16

Abdominal sacral resection of locally recurrent rectal cancer. Ann Surg (1981) 1.16

Surgical principles for pancreatic cancer: regional total and subtotal pancreatectomy. Cancer (1981) 1.16

Histologically positive esophageal margin in the surgical treatment of gastric cancer. Am J Surg (1980) 1.14

Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript. Am J Pathol (1995) 1.13

Recent advances in pancreatic cancer. Surg Clin North Am (1974) 1.13

Clinical liver heterotopic (auxiliary) transplantation. Surgery (1973) 1.11

Pancreatic fistula complicating pancreatectomy for malignant disease. Br J Surg (1981) 1.11

Immunologic reactivity in patients with primary operable breast cancer. Cancer (1978) 1.10

Gardner's syndrome complicated by mesenteric desmoid tumors. Surgery (1979) 1.09

Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study. J Clin Oncol (1987) 1.08

Pelvic recurrence of rectal cancer. Options for curative resection. Ann Surg (1987) 1.07

Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg (1997) 1.07

Wound coverage by a sheet of epidermal cells grown in vitro from dispersed single cell preparations. Surgery (1980) 1.07

Acute renal failure after ligation of the hepatic artery. Surg Gynecol Obstet (1976) 1.06

Technique of regional subtotal and total pancreatectomy. Am J Surg (1985) 1.06

Glomerular basement membrane--reactive antibody in anti-lymphocyte globulin. J Clin Invest (1971) 1.05

Is carcinoma of the gallbladder a curable lesion? Ann Surg (1982) 1.05

Phase II trial of paclitaxel in patients with soft-tissue sarcoma. Cancer Invest (1998) 1.05

Coagulation abnormalities associated with liver transplantation. Surgery (1970) 1.05

Anastomotic recurrence in the oesophagus complicating gastrectomy for adenocarcinoma of the stomach. Br J Surg (1979) 1.05

Meningitis due to lymphocytic choriomeningitis virus endemic in a hamster colony. JAMA (1969) 1.04

Multifocal extremity sarcoma: an uncommon and controversial entity. Ann Surg Oncol (1998) 1.04

Gastric carcinoma after treatment of ulcer. Am J Surg (1980) 1.03

Isolation and perfusion of the liver of cancer chemotherapy. J Surg Res (1973) 1.02